These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2893167)

  • 21. Thalidomide induction of bone marrow transplantation tolerance.
    Vogelsang GB; Hess AD; Gordon G; Brundrette R; Santos GW
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2658-61. PubMed ID: 3547944
    [No Abstract]   [Full Text] [Related]  

  • 22. Quest to improve marrow transplant success yields new approaches to graft-vs-host disease.
    Kirn TF
    JAMA; 1987 Sep; 258(11):1438-9. PubMed ID: 3306001
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment with apremilast was beneficial for chronic graft-versus-host disease skin lesion in a patient with psoriasis.
    Ichiyama S; Komatsu T; Hoashi T; Kanda N; Nagai K; Yamada Y; Ansai SI; Saeki H
    J Dermatol; 2019 Jun; 46(6):e218-e219. PubMed ID: 30632183
    [No Abstract]   [Full Text] [Related]  

  • 24. Combination low-dose thalidomide and cyclosporine prophylaxis for acute graft-versus-host disease in a rat mismatched model.
    Vogelsang GB; Wells MC; Santos GW; Chen TL; Hess AD
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):226-8. PubMed ID: 3284069
    [No Abstract]   [Full Text] [Related]  

  • 25. Thalidomide responsive chronic pulmonary GVHD.
    Forsyth CJ; Cremer PD; Torzillo P; Iland HJ; Young GA
    Bone Marrow Transplant; 1996 Feb; 17(2):291-3. PubMed ID: 8640183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The potential use of thalidomide in the therapy of graft-versus-host disease--a review of clinical and laboratory information.
    Wood PM; Proctor SJ
    Leuk Res; 1990; 14(5):395-9. PubMed ID: 2189044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thalidomide--the need for a new clinical evaluation of an old drug.
    Ehninger G; Eger K; Stuhler A; Schuler U
    Bone Marrow Transplant; 1993; 12 Suppl 3():S26-8. PubMed ID: 8124253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thalidomide after allogeneic haematopoietic stem cell transplantation: activity in chronic but not in acute graft-versus-host disease.
    Kulkarni S; Powles R; Sirohi B; Treleaven J; Saso R; Horton C; Atra A; Ortin M; Rudin C; Goyal S; Sankpal S; Meller S; Pinkerton CR; Mehta J; Singhal S
    Bone Marrow Transplant; 2003 Jul; 32(2):165-70. PubMed ID: 12838281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thalidomide in chronic graft-versus-host disease after stem cell transplantation: effects on quality of life.
    Miller S; Sharda S; Rodrigue J; Mehta P
    Int J Hematol; 2002 Nov; 76(4):365-9. PubMed ID: 12463602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Response to thalidomide therapy in refractory chronic graft-versus-host disease.
    Browne PV; Weisdorf DJ; DeFor T; Miller WJ; Davies SM; Filipovich A; McGlave PB; Ramsay NK; Wagner J; Enright H
    Bone Marrow Transplant; 2000 Oct; 26(8):865-9. PubMed ID: 11081386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sclerodermatous chronic graft-versus-host disease--a report of four pediatric cases.
    Tolland JP; Devereux C; Jones FC; Bingham EA
    Pediatr Dermatol; 2008; 25(2):240-4. PubMed ID: 18429789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Thalidomide once more in the spotlight].
    de Jong-van den Berg LT; Rutgers J; Cornel MC
    Ned Tijdschr Geneeskd; 1998 Nov; 142(46):2509-12. PubMed ID: 10028338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thalidomide for chronic graft-versus-host disease in children.
    Heney D; Lewis IJ; Bailey CC
    Lancet; 1988 Dec; 2(8623):1317. PubMed ID: 2904042
    [No Abstract]   [Full Text] [Related]  

  • 34. Evaluation of thalidomide for treatment or prevention of chronic graft-versus-host disease.
    Flowers ME; Martin PJ
    Leuk Lymphoma; 2003 Jul; 44(7):1141-6. PubMed ID: 12916865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Graft-versus-host disease.
    Kaitin KI
    N Engl J Med; 1991 Aug; 325(5):357-8. PubMed ID: 2057040
    [No Abstract]   [Full Text] [Related]  

  • 36. Efficacy of thalidomide therapy for extramedullary relapse of myeloma following allogeneic transplantation.
    Biagi JJ; Mileshkin L; Grigg AP; Westerman DW; Prince HM
    Bone Marrow Transplant; 2001 Dec; 28(12):1145-50. PubMed ID: 11803357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extensive chronic graft-versus-host disease of skin successfully treated with thalidomide.
    Nair V; Sharma A; Ghosh I; Arora S; Sahai K; Dutta V
    J Assoc Physicians India; 2005 Nov; 53():988-90. PubMed ID: 16515241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thalidomide treatment for chronic graft-versus-host disease.
    Heney D; Norfolk DR; Wheeldon J; Bailey CC; Lewis IJ; Barnard DL
    Br J Haematol; 1991 May; 78(1):23-7. PubMed ID: 2043478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute graft-versus-host disease in allogeneic marrow transplantation.
    Parker N; Cohen T
    Nurs Clin North Am; 1983 Sep; 18(3):569-77. PubMed ID: 6351023
    [No Abstract]   [Full Text] [Related]  

  • 40. Phases in a drug's use.
    Duffin J
    CMAJ; 1992 Sep; 147(5):588. PubMed ID: 1521204
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.